hot news
Actos is a drug that is commonly prescribed for the treatment of type two diabetes in adults. It helps control blood sugar . The use of Actos is associated with a lot of harmful side effects, particularly bladder cancer .
Are you at risk of developing bladder cancer?
The risk of developing bladder cancer reportedly rises as the duration of use of Actos increases. According to the warning issued by the Food and Administration (FDA) in June 2011, those who continue taking the drug for more than a year are more likely to suffer from bladder cancer. This conclusion is drawn with the help of the analyzed data from an ongoing epidemiological study ten years. The study indicated first that, if not well was an overall increase in the risk of bladder cancer by users of Actos, an increased level of risk was seen in those patients who had been exposed to high cumulative doses of the drug for a relatively long period of time. An association with Actos or pioglitazone also reported by the American Diabetes Association. This observation was included in the results of a study that was published in the journal Diabetes Care April 2011 vol.34, No. 4. It was concluded that there was an association between bladder cancer and the use of Acts it stretched beyond 2 years.
Interestingly, a link between Actos and bladder cancer has been recognized by the drug manufacturer itself. Research and analysis conducted by Takeda Pharmaceuticals revealed that diabetic patients who have had Actos for more than two years face an increased risk of developing bladder cancer and the duration of its prolonged use. Halfway results of this study 10 years were submitted to the FDA in 2010 against which the US government agency came out with a drug safety communication.
If continued use of Actos?
All risk factors should be taken into account well in advance and follow-up sessions should be scheduled with those who have been prescribed the drug. In deciding whether to continue the use of Actos, the benefits have been derived from the use of the drug should be considered in relation to the risks.
Moreover, in August 2011, the Food and Drug Administration (FDA) updated the labels of medicines in order to increase awareness of the use of Actos. The revised drug labels indicated that use of Actos over a year increases the likelihood of developing bladder cancer. The label also suggested that doctors should not prescribe the drug to patients with cancer, overactive bladder or history of the disease and patients should immediately consult your health care provider if experiencing any unusual symptoms such as blood in the urine, appearance or worsening urinary urgency or painful urination. Such conditions, if experienced after using Actos, can generally be linked to bladder cancer.
Are you entitled to compensation?
If you or someone you know has developed bladder cancer after using Actos, you or they should consider filing a lawsuit. a demand for this type can claim compensation for expenses incurred during treatment, as well as take into account the pain and suffering that has been experienced. Therefore, it is advisable to seek the services of a lawyer who handles all Actos bladder cancer lawsuits.
There is also a page form that can be used to share the details of your particular case and more information that will help you understand better.
